Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Innoviva (INVA)

Innoviva appoints Derek Small to board of directors effective April 29, 2024

Neutral Impact 2 of 5 leadership Written later

Innoviva, Inc. appointed Derek Small as a director effective April 29, 2024. The board has determined he is independent under SEC and Nasdaq rules, and he will receive director compensation including a $125,000 initial RSU award and a $50,000 annual cash retainer.

Key points

  • Derek Small appointed to the Board effective April 29, 2024; he is a Managing Director at Luson Bioventures and former CEO of Assembly Biosciences.
  • Initial RSU award valued at $125,000, vesting in equal annual installments over two years.
  • Annual cash retainer of $50,000 for board service, plus a prorated annual RSU award of $18,750 and options to purchase 833 shares.

The filing

CompanyInnoviva (INVA)
Form8-K, current report
Filed with the SECApr 29, 2024, 6:14 PM ET
Accession number0001193125-24-123033

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.